(PharmaNewsWire.Com, January 09, 2018 ) The North America Cannabis Testing Market was worth USD 292 million in 2016 and estimated to be growing at a CAGR of 13.1%, to reach USD 541 million by 2021. Cannabis Testing methods detect cannabis use in the fields of medicine, sport and law. Some of the many ways in which the usage is detected are hair testing, urine testing, saliva testing and blood testing among others. Dissimilar to the alcohol detection by using breathalysers, discern usage of cannabis by using any method a lot of time. Tests like Duquenois-Levine can quickly detect cannabis use, but it’s not definitive since it gives positive results for other substances as well.
Usage of cannabis by taking urine samples can be recognised up to 2-5 days after usage in infrequent users and in heavy users it can be detected in a window of 15 days. By saliva testing, abuse can be observed in a window of 3 days, but it can detect compounds with concentration even in the range of 0.5 ng/mL. Blood testing is not a normally used procedure since it is invasive. It can detect usage only within 12-24 hours of time period in infrequent users and 7 days in heavy users. By hair testing usage can be detected even after 90 days of exposure and can make out from concentrations as low as 1 pg/mg of sample.
Some of the driving factors of North America Cannabis testing market are increasing accidents under cannabis intoxication, cannabis legalisation for medical and recreational purposes in some parts of the world, expanding seminars and conferences to increase awareness about the tests, growing usage of LIMS and expansion of cannabis testing laboratories among others. A few constraints that this market is facing are less number of skilled professionals, high price of instruments for testing cannabis usage, and presence of alternative technologies.
The North America Cannabis Testing market is segmented on the basis of product & software into analytical instruments, consumables and software. Based on testing procedures, the market is divided into terpene profiling, potency testing, residual solvent screening, pesticide screening, genetic testing, heavy metal testing and microbial analysis. Potency testing has the highest market share in this segment. On the basis of end-users, the market is divided into cannabis cultivators, laboratories, drug manufacturers & dispensaries, and research institutes. Laboratories accounted for the largest market share in this segment owing to rising demand for cannabis testing software in labs.
The North America market for Cannabis Testing is geographically segmented into United States, Canada and Mexico. United States accounted for the largest market share in this segment and is also the fastest growing, which can be owed to factors like legalisation of cannabis for medical use as well as recreational purposes in many parts of US.
Some of the major players in the market include Agilent Technologies, Inc., Shimadzu Corporation, Waters Corporation, PerkinElmer, Inc., AB SCIEX LLC, Millipore Sigma, Restek Corporation, LabLynx, Inc. (U.S.), Steep Hill Labs, Inc., PharmLabs, LLC, SC Laboratories, Inc., Digipath Labs, Inc., CannaSafe Analytics, and Accelerated Technology Laboratories, Inc.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
